monoamine oxidase B inhibitor (BioSolveIT/University of Bonn)

N/A

Report date: 2025/06/11 10:29:50
NME

Base Information

Drug Namemonoamine oxidase B inhibitor (BioSolveIT/University of Bonn)
Drug Alias NameNTZ-1034NTZ-2020PSB-1034NTZ-1441NTZ-2027 +[7] 
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionMonoamine oxidase B inhibitorsNeuroprotectantsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase BMonoamine oxidase A
Therapy Area/IndicationsMental DisordersAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bonn
China Registration ClassN/A

Develop Information

Active CompaniesBioSolveIT GmbHNtz Lab LtdUniversity Of Bonn
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A